Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Teva Pharmaceutical Industries Limited American Depositary Shares (NY:TEVA)

34.03 -0.30 (-0.86%)
Streaming Delayed Price Updated: 3:27 PM EST, Feb 20, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Teva Pharmaceutical Industries Limited American Depositary Shares

< Previous 1 2
...
12 13 14 15 16 17 18 19 20
...
22 23 Next >
News headline image
Will Bed Bath & Beyond (BBBY) Stock Really Fall to $1? ↗
Bed Bath & Beyond (BBBY) stock is in the news today after an incredibly bearish analyst said the retailer's shares will fall to $1 a piece. 
Via InvestorPlace
News headline image
What Is Going on With Teva Pharmaceuticals (TEVA) Stock Today? ↗
TEVA stock, already trading far below its prior peak, may come under pressure in the near future due to the threat of ongoing litigation. 
Via InvestorPlace
News headline image
New York Attorney General Says Teva Tried To Evade Accountability On Opioid Crisis: Report ↗
Reuters reported that New York's attorney general said Teva Pharmaceutical Industries Ltd (NY 
Via Benzinga
News headline image
Analyst Ratings for Teva Pharmaceutical Indus ↗
Within the last quarter, Teva Pharmaceutical Indus (NYSE:TEVA) has observed the following analyst ratings: 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For June 14, 2022 ↗
Upgrades 
Via Benzinga
News headline image
Why Generic Drugs Giant Teva Pharmaceutical Just Cut Its 2022 Outlook ↗
Foreign exchange rates are weighing heavily on sales, according to the firm's CEO. 
Via Investor's Business Daily
News headline image
Golden Cross Appears Before Teva Pharmaceutical Indus Investors ↗
If history is any guide, there may be good fortune ahead for shares of Teva Pharmaceutical Indus (NYSE:TEVA). A so-called "golden cross" has formed on its chart and, not surprisingly, this could be... 
Via Benzinga
News headline image
Teva, Allergan Settle Opioid Lawsuit With West Virginia ↗
U.S. affiliate of Teva Pharmaceutical Industries Ltd (NYSE: TEVA) has reached an agreement with the Attorney General of West Virginia that settles the state's opioid-related claims. 
Via Benzinga
News headline image
Teva Pharmaceutical Shares Real-World Data Of ProAir Digihaler In Asthma Patients ↗
 
Via Benzinga
News headline image
BofA Upgrades Teva Pharmaceutical On Possible Opioid Deal ↗
Prospects of a global opioid deal getting done in 2022 suggest a “potential path to upside” for Teva Pharmaceutical Industries Ltd.’s (NYSE: TEVA) stock, according to BofA Securities. 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For May 17, 2022 ↗
 
Via Benzinga
News headline image
FDA Rejects Teva - MedinCell's Schizophrenia Candidate ↗
 
Via Benzinga
News headline image
4 Analysts Have This to Say About Teva Pharmaceutical Indus ↗
Over the past 3 months, 4 analysts have published their opinion on Teva Pharmaceutical Indus (NYSE:TEVA) stock. These analysts are typically employed by large Wall Street banks and tasked with... 
Via Benzinga
News headline image
Teva, Allergan Ready To Pay $5B To Settle Lawsuits Related To Opioid Painkillers: Bloomberg ↗
 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For May 4, 2022 ↗
Upgrades 
Via Benzinga
News headline image
Teva Posts Mixed Q1 Earnings, Cuts FY22 Sales Guidance Citing Copaxone Competition, Yet Shares Rise ↗
 
Via Benzinga
News headline image
The Daily Biotech Pulse: FDA's AdComm For Acadia's Pimavanserin, Review Issues For Spero's Tebipenem Application, Cortexyme Layoffs ↗
Here's a roundup of top developments in the biotech space over the last 24 hours. 
Via Benzinga
News headline image
Recap: Teva Pharmaceutical Q1 Earnings ↗
Teva Pharmaceutical Indus (NYSE:TEVA) reported its Q1 earnings results on Tuesday, May 3, 2022 at 07:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
News headline image
The Week Ahead In Biotech (May 1-7): Phathom FDA Decision, Pfizer, Vertex Pharma Lead Earnings News, Ophthalmology Conference Presentations, And More ↗
Biotech stocks posted weekly declines yet again in the week ending April 29, taking cues from the weak broader market sentiment. Big pharma earnings, clinical readouts and pipeline updates moved stocks... 
Via Benzinga
News headline image
Earnings Scheduled For May 3, 2022 ↗
Companies Reporting Before The Bell • Kiniksa Pharmaceuticals (NASDAQ:KNSA) is projected to report earnings for its first quarter. 
Via Benzinga
News headline image
San Francisco To Start Opioid Epidemic Trial Against Teva, Walgreen: Reuters ↗
 
Via Benzinga
News headline image
JNJ, McKesson, Endo Settle $275M Opioid Claims With Alabama: Reuters ↗
 
Via Benzinga
News headline image
The Daily Biotech Pulse: Windtree Jumps On Istaroxime Data, Arcturus' COVID-19 Vaccine Trial Data, FDA Rejects Teva's Schizophrenia Med, Otonomy Aces Hearing Loss Study ↗
Here's a roundup of top developments in the biotech space over the last 24 hours. 
Via Benzinga
News headline image
What Were Your Best And Worst Stock Buys? What Does The Zinger Nation Think? ↗
Admitting to success is a lot easier than failure and when it comes to stocks, not only is there money involved, but also questioning your — or your advisor's — judgment. And then there is the advice... 
Via Benzinga
News headline image
Good and Bad stock news ↗
Microsoft is down because of an FTC investigation of its possible anti-competitive moves. 
Via Talk Markets
News headline image
Futures Slide To Overnight Lows As Algos Spooked By EU Ban On Russian Coal ↗
After initially trading sharply higher around the European open, US stock futures dropped to session lows as traders digested the latest developments in the Ukraine war. 
Via Talk Markets
News headline image
West Virginia Says J&J, Teva, AbbVie Caused 'Tsunami' Of Opioid Addiction: Reuters ↗
West Virginia's attorney general urged a judge to hold Johnson & Johnson (NYSE: JNJ), Teva Pharmaceuticals Industries Ltd (NYSE: TEVA), and AbbVie Inc's (NYSE: 
Via Benzinga
News headline image
CVS Health, Teva Settle Florida State's Opioid-Related Claims: Report ↗
Florida has reached more than $878 million in settlements with CVS Health Corp (NYSE: CVS) and three drug companies to resolve claims and avert a trial next month over their roles in fueling an opioid... 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For April 5, 2022 ↗
Upgrades 
Via Benzinga
News headline image
Monday Markets News ↗
Japanese Takeda TAK shares failed to thrive after its edema prevention drug was approved. 
Via Talk Markets
< Previous 1 2
...
12 13 14 15 16 17 18 19 20
...
22 23 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.